journal article·2025-07Open access

Green-synthesized gold nanoparticles exhibit neuroprotective activity against oxidative stress-induced damage in SH-SY5Y cells

Z. Nkentsha, S. Rambharose

Journal of Nanoparticle Research· Volume 27· Issue 7

Abstract

Abstract Neurodegenerative diseases such as Alzheimer’s are strongly driven by oxidative stress, yet existing antioxidant therapies are limited by low bioavailability and poor blood–brain barrier (BBB) penetration. In this study, we report the green synthesis of gold nanoparticles (AuNPs) using three distinct phytochemicals (morin hydrate, polydatin, and berberine chloride) and demonstrate their potent neuroprotective effects against oxidative stress-induced damage in SH-SY5Y cells. Synthesized AuNPs were characterized via UV–visible spectroscopy, DLS, SEM, FTIR, and zeta potential analysis. Antioxidant potential was assessed using DPPH, WST-1, TBARS, DCFH-DA assays, and confocal microscopy in paraquat-induced oxidative stress in SH-SY5Y cells. All phytochemically synthesized AuNPs demonstrated excellent colloidal stability (zeta potential > ± 30 mV), spherical-to-cuboidal morphology, and sizes < 150 nm. They exhibited superior ROS scavenging capacity and biocompatibility relative to conventional AuNPs and parent phytochemical compounds. Notably, polydatin-AuNPs significantly reduced lipid peroxidation and cellular ROS to baseline levels. These results suggest green-synthesized AuNPs as promising therapeutic nanoplatforms for mitigating oxidative stress in neurodegenerative disorders.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoparticles: synthesis and applications · Advanced Nanomaterials in Catalysis · Biochemical effects in animals

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (88)

Show source-provided references
1. Swerdlow RH (2011) Brain aging Alzheimer’s disease, and mitochondria. Biochim Biophys Acta Mol Basis Dis 1812(12):1630–163910.1016/j.bbadis.2011.08.012 ↗
2. Chen Z, Zhong C (2014) Oxidative stress in Alzheimer’s disease. Neurosci Bull 30:271–281. https://doi.org/10.1007/s12264-013-1423-y10.1007/s12264-013-1423-y ↗
3. Kim GH, Kim JE, Rhie SJ, Yoon S (2015) The role of oxidative stress in neurodegenerative diseases. Exper Neurobiol 24(4):325. https://doi.org/10.5607/en.2015.24.4.32510.5607/en.2015.24.4.325 ↗
4. Bai R, Guo J, Ye XY, Xie Y, Xie T (2022) Oxidative stress: the core pathogenesis and mechanism of Alzheimer’s disease. Ageing Res Rev 77:101619. https://doi.org/10.1016/j.arr.2022.10161910.1016/j.arr.2022.101619 ↗
5. Congdon EE, Ji C, Tetlow AM, Jiang Y, Sigurdsson EM (2023) Tau-targeting therapies for Alzheimer disease: current status and future directions. Nat Rev Neurol 19(12):715–736. https://doi.org/10.1038/s41582-023-00883-210.1038/s41582-023-00883-2 ↗
6. Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, Jacobs AH, Wyss-Coray T, Vitorica J, Ransohoff RM, Herrup K (2015) Neuroinflammation in Alzheimer’s disease. Lancet Neurol 14(4):388–405. https://doi.org/10.1016/S1474-4422(15)70016-510.1016/S1474-4422(15)70016-5 ↗
7. Yiannopoulou KG, Papageorgiou SG (2020) Current and future treatments in Alzheimer disease: an update. J Central Nerv Syst Dis 12:1179573520907397. https://doi.org/10.1177/117957352090739710.1177/1179573520907397 ↗
8. Rahman MM, Islam MR, Akash S, Harun-Or-Rashid M, Ray TK, Rahaman MS, Islam M, Anika F, Hosain MK, Aovi FI, Hemeg HA (2022) Recent advancements of nanoparticles application in cancer and NDs: at a glance. Biomed Pharmacother 153:113305. https://doi.org/10.1016/j.biopha.2022.11330510.1016/j.biopha.2022.113305 ↗
9. Herizchi R, Abbasi E, Milani M, Akbarzadeh A (2016) Current methods for synthesis of gold nanoparticles. Artif Cells Nanomed Biotechnol 44(2):596–602. https://doi.org/10.3109/21691401.2014.97180710.3109/21691401.2014.971807 ↗
10. Abdul-Hamid M, Galaly SR, Mohamed HM, Mostafa F, Abdel-Moneim A (2023) Polydatin nanoparticles attenuate oxidative stress and histopathological changes in streptozotocin model of diabetic nephropathy: targeting Nrf2/HO-1/NF-κβ signaling pathways. Beni-Suef Univ J Basic Appl Sci 12(1):99. https://doi.org/10.1186/s43088-023-00441-110.1186/s43088-023-00441-1 ↗
11. Vijayalakshmi S, Mariadoss AVA, Ramachandran V, Shalini V, Agilan B, Sangeetha CC, Balu P, Kotakadi VS, Karthikkumar V, Ernest D (2019) Polydatin encapsulated poly [lactic-co-glycolic acid] nanoformulation counteract the 7, 12-dimethylbenz [a] anthracene mediated experimental carcinogenesis through the inhibition of cell proliferation. Antioxidants 8(9):375. https://doi.org/10.3390/antiox809037510.3390/antiox8090375 ↗
12. Larrañaga-Tapia M, Betancourt-Tovar B, Videa M, Antunes-Ricardo M, Cholula-Díaz JL (2024) Green synthesis trends and potential applications of bimetallic nanoparticles towards the sustainable development goals 2030. Nanoscale Adv 6(1):51–71. https://doi.org/10.1039/D3NA00761H10.1039/D3NA00761H ↗
13. Dykman LA, Khlebtsov NG (2011) Gold nanoparticles in biology and medicine: recent advances and prospects. Acta Naturae (aнглoязычнaя вepcия) 2(9):34–55. https://doi.org/10.1039/C0CS00018C10.1039/C0CS00018C ↗
14. Jara-Guajardo P, Cabrera P, Celis F, Soler M, Berlanga I, Parra-Muñoz N, Acosta G, Albericio F, Guzman F, Campos M, Alvarez A (2020) Gold nanoparticles mediate improved detection of β-amyloid aggregates by fluorescence. Nanomaterials 10(4):690. https://doi.org/10.3390/nano1004069010.3390/nano10040690 ↗
15. dos Santos Tramontin N, da Silva S, Arruda R, Ugioni KS, Canteiro PB, de Bem Silveira G, Mendes C, Silveira PCL, Muller AP (2020) Gold nanoparticles treatment reverses brain damage in Alzheimer’s disease model. Mol Neurobiol 57:926–936. https://doi.org/10.1007/s12035-019-01780-w10.1007/s12035-019-01780-w ↗
16. Sundus Jabeen A, Guo B (2020) A review on the synthesis and functionalization of gold nanoparticles as a drug delivery vehicle. Int J Nanomed 9823–9857. https://doi.org/10.2147/IJN.S27909410.2147/IJN.S279094 ↗
17. Tada H, Fujishima M, Naya SI (2024) Fundamentals and applications of gold nanoparticle-based plasmonic photocatalysts for water purification. ACS ES&T Eng 4(3):506–524. https://doi.org/10.1021/acsestengg.3c0053910.1021/acsestengg.3c00539 ↗
18. Jaeger R, Cuny E (2016) Terpenoids with special pharmacological significance: A review. Nat Prod Commun 11(9):1934578X1601100946. https://doi.org/10.1177/1934578X160110094610.1177/1934578X1601100946 ↗
19. Kumar APN, Kumar M, Jose A, Tomer V, Oz E, Proestos C, Zeng M, Elobeid TKS, Oz F (2023) Major phytochemicals: recent advances in health benefits and extraction method. Molecules 28(2):887. https://doi.org/10.3390/molecules2802088710.3390/molecules28020887 ↗
20. Sharma BR, Kumar V, Gat Y, Kumar N, Parashar A, Pinakin DJ (2018) Microbial maceration: a sustainable approach for phytochemical extraction. 3 Biotech 8:1–13. https://doi.org/10.1007/s13205-018-1423-810.1007/s13205-018-1423-8 ↗
21. Tsele-Tebakang T, Morris-Eyton H, Pretorius E (2023) Concurrent use of herbal and prescribed medicine by patients in primary health care clinics, South Africa. Afr J Prim Health Care Fam Med 15(1):3829. https://hdl.handle.net/10520/ejc-phcfm_v15_n1_a382910.4102/phcfm.v15i1.3829 ↗
22. Gopal JV (2013) Morin hydrate: botanical origin, pharmacological activity and its applications: a mini-review. Pharmacogn J 5(3):123–126. https://doi.org/10.1016/j.phcgj.2013.04.00610.1016/j.phcgj.2013.04.006 ↗
23. Rajput SA, Wang XQ, Yan HC (2021) Morin hydrate: a comprehensive review on novel natural dietary bioactive compound with versatile biological and pharmacological potential. Biomed Pharmacother 138:111511. https://doi.org/10.1016/j.biopha.2021.11151110.1016/j.biopha.2021.111511 ↗
24. Singh M, Thakur V, Deshmukh R, Sharma A, Rathore MS, Kumar A, Mishra N (2018) Development and characterization of morin hydrate-loaded micellar nanocarriers for the effective management of Alzheimer’s disease. J Microencapsul 35(2):137–148. https://doi.org/10.1080/02652048.2018.144191610.1080/02652048.2018.1441916 ↗
25. Ben-Azu B, Aderibigbe AO, Eneni AEO, Ajayi AM, Umukoro S, Iwalewa EO (2018) Morin attenuates neurochemical changes and increased oxidative/nitrergic stress in brains of mice exposed to ketamine: prevention and reversal of schizophrenia-like symptoms. Neurochem Res 43:1745–1755. https://doi.org/10.1007/s11064-018-2590-z10.1007/s11064-018-2590-z ↗
26. Kondath S, Raghavan BS, Anantanarayanan R, Rajaram R (2014) Synthesis and characterisation of morin reduced gold nanoparticles and its cytotoxicity in MCF-7 cells. Chem Biol Interact 224:78–88. https://doi.org/10.1016/j.cbi.2014.09.02510.1016/j.cbi.2014.09.025 ↗
27. Fakhri S, Gravandi MM, Abdian S, Akkol EK, Farzaei MH, Sobarzo-Sánchez E (2021) The neuroprotective role of polydatin: neuropharmacological mechanisms, molecular targets, therapeutic potentials, and clinical perspective. Molecules 26(19):5985. https://doi.org/10.3390/molecules2619598510.3390/molecules26195985 ↗
28. Karami A, Fakhri S, Kooshki L, Khan H (2022) Polydatin: pharmacological mechanisms, therapeutic targets, biological activities, and health benefits. Molecules 27(19):6474. https://doi.org/10.3390/molecules2719647410.3390/molecules27196474 ↗
29. Wang X, Shan P, Liu A, Ma L, Lu M, Jiang W, Li N (2017) Polydatin prevents A beta-induced neuron cytotoxicity via enhancing autophagy and decreasing oxidative stress. Int J Clin Exp Med 10(11):15250–15259
30. Liu N, Yu Z, Gao X, Song S, Yuan J, Xun Y, Wang T, Yan F, Yuan S, Zhang J, Xiang S (2016) Establishment of cell-based neuroglobin promoter reporter assay for neuroprotective compounds screening. CNS Neurol Disord Drug Targets 15(5):629–639. https://doi.org/10.2174/187152731566616032110561210.2174/1871527315666160321105612 ↗
31. Samra YA, Abdelghany AM, Zaghloul RA (2021) Polydatin gold nanoparticles potentiate antitumor effect of doxorubicin in Ehrlich ascites carcinoma-bearing mice. J Biochem Mol Toxicol 35(10):e22869. https://doi.org/10.1002/jbt.2286910.1002/jbt.22869 ↗
32. Och A, Podgórski R, Nowak R (2020) Biological activity of berberine—A summary update. Toxins 12(11):713. https://doi.org/10.3390/toxins1211071310.3390/toxins12110713 ↗
33. Sobolova K, Hrabinova M, Hepnarova V, Kucera T, Kobrlova T, Benkova M, Janockova J, Dolezal R, Prchal L, Benek O, Mezeiova E (2020) Discovery of novel berberine derivatives with balanced cholinesterase and prolyl oligopeptidase inhibition profile. Eur J Med Chem 203:112593. https://doi.org/10.1016/j.ejmech.2020.11259310.1016/j.ejmech.2020.112593 ↗
34. Chiu CF, Fu RH, Hsu SH, Yu YH, Yang SF, Tsao TCY, Chang KB, Yeh CA, Tang CM, Huang SC, Hung HS (2021) Delivery capacity and anticancer ability of the berberine-loaded gold nanoparticles to promote the apoptosis effect in breast cancer. Cancers 13(21):5317. https://doi.org/10.3390/cancers1321531710.3390/cancers13215317 ↗
35. Pandey S, Mewada A, Thakur M, Shah R, Oza G, Sharon M (2013) Biogenic gold nanoparticles as fotillas to fire berberine hydrochloride using folic acid as molecular road map. Mater Sci Eng, C 33(7):3716–3722. https://doi.org/10.1016/j.msec.2013.05.00710.1016/j.msec.2013.05.007 ↗
36. Tenório MCDS, Graciliano NG, Moura FA, Oliveira ACMD, Goulart MOF (2021) N-acetylcysteine (NAC): impacts on human health. Antioxidants 10(6):967. https://doi.org/10.3390/antiox1006096710.3390/antiox10060967 ↗
37. Gęgotek A, Skrzydlewska E (2023) Ascorbic acid as antioxidant. Vitam Horm 121:247–270. https://doi.org/10.1016/bs.vh.2022.10.00810.1016/bs.vh.2022.10.008 ↗
38. Brubacher JL, Bols NC (2001) Chemically de-acetylated 2′, 7′-dichlorodihydrofluorescein diacetate as a probe of respiratory burst activity in mononuclear phagocytes. J Immunol Methods 251(1–2):81–91. https://doi.org/10.1016/S0022-1759(01)00308-810.1016/S0022-1759(01)00308-8 ↗
39. Karlsson M, Kurz T, Brunk UT, Nilsson SE, Frennesson CI (2010) What does the commonly used DCF test for oxidative stress really show? Biochemical Journal 428(2):183–190. https://doi.org/10.1042/BJ2010020810.1042/BJ20100208 ↗
40. Roesslein M, Hirsch C, Kaiser JP, Krug HF, Wick P (2013) Comparability of in vitro tests for bioactive nanoparticles: a common assay to detect reactive oxygen species as an example. Int J Mol Sci 14(12):24320–24337. https://doi.org/10.3390/ijms14122432010.3390/ijms141224320 ↗
41. De Leon JAD, Borges CR (2020) Evaluation of oxidative stress in biological samples using the thiobarbituric acid reactive substances assay. J Visual Exper (159). https://doi.org/10.3791/6112210.3791/61122 ↗
42. Ren SH, Zhang JQ, Yan HH, Zheng X, Zhu HY, Jin Y, Lin J (2016) Preparation, characterization, molecular docking and in vitro evaluation of two novel morin hydrate/CD inclusion complexes. J Incl Phenom Macrocycl Chem 85:317–328. https://doi.org/10.1007/s10847-016-0631-210.1007/s10847-016-0631-2 ↗
43. Battu SK, Repka MA, Maddineni S, Chittiboyina AG, Avery MA, Majumdar S (2010) Physicochemical characterization of berberine chloride: a perspective in the development of a solution dosage form for oral delivery. AAPS PharmSciTech 11:1466–1475. https://doi.org/10.1208/s12249-010-9520-y10.1208/s12249-010-9520-y ↗
44. Pluchery O, Prado Y, Watkins W (2023) A complete explanation of the plasmonic colours of gold nanoparticles and of the bichromatic effect. J Mater Chem C 11(45):15824–15832. https://doi.org/10.1039/D3TC02669H10.1039/D3TC02669H ↗
45. Link S, El-Sayed MA (1999) Spectral properties and relaxation dynamics of surface plasmon electronic oscillations in gold and silver nanodots and nanorods. J Phys Chem B 103(40):8410–8426. https://doi.org/10.1021/jp991764810.1021/jp9917648 ↗
46. Amendola V, Meneghetti M (2009) Laser ablation synthesis in solution and size manipulation of noble metal nanoparticles. Phys Chem Chem Phys 11(20):3805–3821. https://doi.org/10.1039/B900654K10.1039/B900654K ↗
47. Al-Qadi K, Saadah B (2015) Gold nanoparticles: size vs. color University of Illinois,ideals.illinois.edu https://hdl.handle.net/2142/75909. Accessed 18 Dec 2024
48. Hail CU, Schnoering G, Damak M, Poulikakos D, Eghlidi H (2020) A plasmonic painter’s method of color mixing for a continuous red–green–blue palette. ACS Nano 14(2):1783–1791. https://doi.org/10.1021/acsnano.9b0752310.1021/acsnano.9b07523 ↗
49. Gao X, Wang Q, Zhang S, Hong R, Zhang D (2022) Angle robust reflected plasmonic color palettes with expanded color gamut. Optics Commun 517:128341. https://doi.org/10.1016/j.optcom.2022.12834110.1016/j.optcom.2022.128341 ↗
50. Petryayeva E, Krull UJ (2011) Localized surface plasmon resonance: Nanostructures, bioassays and biosensing—A review. Anal Chim Acta 706(1):8–24. https://doi.org/10.1016/j.aca.2011.08.02010.1016/j.aca.2011.08.020 ↗
51. Sadeghi B, Mohammadzadeh M, Babakhani B (2015) Green synthesis of gold nanoparticles using Stevia rebaudiana leaf extracts: characterization and their stability. J Photochem Photobiol B Biol 148:101–106. https://doi.org/10.1016/j.jphotobiol.2015.03.02510.1016/j.jphotobiol.2015.03.025 ↗
52. Aromal SA, Philip D (2012) Green synthesis of gold nanoparticles using Trigonella foenum-graecum and its size-dependent catalytic activity. Spectrochim Acta Part A Mol Biomol Spectrosc 97:1–5. https://doi.org/10.1016/j.saa.2012.05.08310.1016/j.saa.2012.05.083 ↗
53. Woźniak A, Malankowska A, Nowaczyk G, Grześkowiak BF, Tuśnio K, Słomski R, Zaleska-Medynska A, Jurga S (2017) Size and shape-dependent cytotoxicity profile of gold nanoparticles for biomedical applications. J Mater Sci - Mater Med 28:1–11. https://doi.org/10.1007/s10856-017-5902-y10.1007/s10856-017-5902-y ↗
54. Mustafa DE, Yang T, Xuan Z, Chen S, Tu H, Zhang A (2010) Surface plasmon coupling effect of gold nanoparticles with different shape and size on conventional surface plasmon resonance signal. Plasmonics 5:221–231. https://doi.org/10.1007/s11468-010-9141-z10.1007/s11468-010-9141-z ↗
55. Menon S, Rajeshkumar S, Kumar V (2017) A review on biogenic synthesis of gold nanoparticles, characterization, and its applications. Resour Effic Technol 3(4):516–527. https://doi.org/10.1016/j.reffit.2017.08.00210.1016/j.reffit.2017.08.002 ↗
56. Sobczak-Kupiec A, Malina D, Zimowska M, Wzorek Z (2011) Characterization of gold nanoparticles for various medical application. Dig J Nanomater Bios 6(2): 803–808. https://www.chalcogen.ro/803_Kupiec.pdf10.1049/mnl.2011.0152 ↗
57. Tembhare E, Gupta KR, Umekar MJ (2019) An approach to drug stability studies and shelf-life determination. Arch Curr Res Int 19(1):1–20. https://doi.org/10.9734/ACRI/2019/v19i13014710.9734/ACRI/2019/v19i130147 ↗
58. Jeevanandam J, Barhoum A, Chan YS, Dufresne A, Danquah MK (2018) Review on nanoparticles and nanostructured materials: history, sources, toxicity and regulations. Beilstein J Nanotechnol 9(1):1050–1074. https://doi.org/10.3762/bjnano.9.9810.3762/bjnano.9.98 ↗
59. Danaei MRMM, Dehghankhold M, Ataei S, Hasanzadeh Davarani F, Javanmard R, Dokhani A, Khorasani S, Mozafari MR (2018) Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics 10(2):57. https://doi.org/10.3390/pharmaceutics1002005710.3390/pharmaceutics10020057 ↗
60. Frens G (1973) Controlled nucleation for the regulation of the particle size in monodisperse gold suspensions. Nat Phys Sci 241(105):20–22. https://doi.org/10.1038/physci241020a010.1038/physci241020a0 ↗
61. Koczkur KM, Mourdikoudis S, Polavarapu L, Skrabalak SE (2015) Polyvinylpyrrolidone (PVP) in nanoparticle synthesis. Dalton Trans 44(41):17883–17905. https://doi.org/10.1039/C5DT02964C10.1039/C5DT02964C ↗
62. Lata K, Arvind KJ, Laxmana N, Rajan S (2014) Gold nanoparticles: preparation, characterization and its stability in buffer. J Nanotechnol Appl 17(1): 1–10. https://www.researchgate.net/publication/267296306_Characterization_of_gold_nanoparticle_for_various_medical_application. Accessed 17 Jun 2025
63. Figueroa-Méndez R, Rivas-Arancibia S (2015) Vitamin C in health and disease: its role in the metabolism of cells and redox state in the brain. Front Physiol 6:397. https://doi.org/10.3389/fphys.2015.0039710.3389/fphys.2015.00397 ↗
64. Tran HM, Yang CY, Wu TH, Yen FL (2022) Liposomes encapsulating morin: investigation of physicochemical properties, dermal absorption improvement and anti-aging activity in pm-induced keratinocytes. Antioxidants 11(6):1183. https://doi.org/10.3390/antiox1106118310.3390/antiox11061183 ↗
65. Jayalakshmi P, Devika PT (2019) Assessment of in vitro antioxidant activity study of polydatin. J Pharmacog Phytochem 8(4):55–58
66. Li Z, Chen X, Liu G, Li J, Zhang J, Cao Y, Miao J (2021) Antioxidant activity and mechanism of resveratrol and polydatin isolated from mulberry (Morus alba L.). Molecules 26(24):7574. https://doi.org/10.3390/molecules2624757410.3390/molecules26247574 ↗
67. Luo A, Fan Y (2011) Antioxidant activities of berberine hydrochloride. J Med Plants Res 5(16):3702–3707. https://doi.org/10.5897/JMPR.900019010.5897/JMPR.9000190 ↗
68. Kinoshita A, Lima I, Guidelli ÉJ, Baffa Filho O (2021) Antioxidative activity of gold and platinum nanoparticles assessed through electron spin resonance. Eclética Química 46:68–74. https://doi.org/10.26850/1678-4618eqj.v46.1SI.2021.p68-7410.26850/1678-4618eqj.v46.1SI.2021.p68-74 ↗
69. Yayintas OT, Demir N, Canbolat F, Ayna TK, Pehlivan M (2024) Characterization, biological activity, and anticancer effect of green-synthesized gold nanoparticles using Nasturtium officinale L. BMC Complement Med Ther 24(1):346. https://doi.org/10.1186/s12906-024-04635-710.1186/s12906-024-04635-7 ↗
70. Anwar SA, Almatroodi S, Almatroudi A, Allemailem KS, Joseph RJ, Khan AA, Alrumaihi F, Alsahli MA, Husain Rahmani A (2021) Biosynthesis of silver nanoparticles using Tamarix articulata leaf extract: an effective approach for attenuation of oxidative stress mediated diseases. Int J Food Prop 24(1):677–701. https://doi.org/10.1080/10942912.2021.191408310.1080/10942912.2021.1914083 ↗
71. Huang YW, Cambre M, Lee HJ (2017) The toxicity of nanoparticles depends on multiple molecular and physicochemical mechanisms. Int J Mol Sci 18(12):2702. https://doi.org/10.3390/ijms1812270210.3390/ijms18122702 ↗
72. Sukhanova A, Bozrova S, Sokolov P, Berestovoy M, Karaulov A, Nabiev I (2018) Dependence of nanoparticle toxicity on their physical and chemical properties. Nanoscale Res Lett 13:1–21. https://doi.org/10.1186/s11671-018-2457-x10.1186/s11671-018-2457-x ↗
73. Pan Y, Neuss S, Leifert A, Fischler M, Wen F, Simon U, Schmid G, Brandau W, Jahnen-Dechent W (2007) Size-dependent cytotoxicity of gold nanoparticles. Small 3(11):1941–1949. https://doi.org/10.1002/smll.20070037810.1002/smll.200700378 ↗
74. Kus-Liśkiewicz M, Fickers P, Ben Tahar I (2021) Biocompatibility and cytotoxicity of gold nanoparticles: recent advances in methodologies and regulations. Int J Mol Sci 22(20):10952. https://doi.org/10.3390/ijms22201095210.3390/ijms222010952 ↗
75. Vijayakumar S, Ganesan S (2012) In vitro cytotoxicity assay on gold nanoparticles with different stabilizing agents. J Nanomater 2012(1):734398. https://doi.org/10.1155/2012/73439810.1155/2012/734398 ↗
76. Kapoor R, Kakkar P (2012) Protective role of morin, a flavonoid, against high glucose induced oxidative stress mediated apoptosis in primary rat hepatocytes. PLoS ONE 7(8):e41663. https://doi.org/10.1371/journal.pone.004166310.1371/journal.pone.0041663 ↗
77. Och A, Zalewski D, Komsta Ł, Kołodziej P, Kocki J, Bogucka-Kocka A (2019) Cytotoxic and proapoptotic activity of sanguinarine, berberine, and extracts of Chelidonium majus L. and Berberis thunbergii DC. toward hematopoietic cancer cell lines. Toxins 11(9):485. https://doi.org/10.3390/toxins1109048510.3390/toxins11090485 ↗
78. Sett A, Gadewar M, Sharma P, Deka M, Bora U (2016) Green synthesis of gold nanoparticles using aqueous extract of Dillenia indica. Adv Nat Sci Nanosci Nanotechnol 7(2):025005. https://doi.org/10.1088/2043-6262/7/2/02500510.1088/2043-6262/7/2/025005 ↗
79. Elia P, Zach R, Hazan S, Kolusheva S, Porat ZE, Zeiri Y (2014) Green synthesis of gold nanoparticles using plant extracts as reducing agents. Int J Nanomed 4007–4021. https://doi.org/10.2147/IJN.S5734310.2147/IJN.S57343 ↗
80. Lee J, Kim HY, Zhou H, Hwang S, Koh K, Han DW, Lee J (2011) Green synthesis of phytochemical-stabilized Au nanoparticles under ambient conditions and their biocompatibility and antioxidative activity. J Mater Chem 21(35):13316–13326. https://doi.org/10.1039/C1JM11592H10.1039/C1JM11592H ↗
81. Gurunathan S, Han J, Park JH, Kim JH (2014) A green chemistry approach for synthesizing biocompatible gold nanoparticles. Nanoscale Res Lett 9:1–11. https://doi.org/10.1186/1556-276X-9-24810.1186/1556-276X-9-248 ↗
82. Elliott AD (2020) Confocal microscopy: principles and modern practices. Curr Protoc Cytom 92(1):e68. https://doi.org/10.1002/cpcy.6810.1002/cpcy.68 ↗
83. Bhatt S, Puli L, Patil CR (2021) Role of reactive oxygen species in the progression of Alzheimer’s disease. Drug Discov Today 26(3):794–803. https://doi.org/10.1016/j.drudis.2020.12.00410.1016/j.drudis.2020.12.004 ↗
84. Bradley-Whitman MA, Lovell MA (2015) Biomarkers of lipid peroxidation in Alzheimer disease (AD): an update. Arch Toxicol 89:1035–1044. https://doi.org/10.1007/s00204-015-1517-610.1007/s00204-015-1517-6 ↗
85. Teleanu DM, Chircov C, Grumezescu AM, Volceanov A, Teleanu RI (2018) Blood-brain delivery methods using nanotechnology. Pharmaceutics 10(4):269. https://doi.org/10.3390/pharmaceutics1004026910.3390/pharmaceutics10040269 ↗
86. Liu XY, Wang JQ, Ashby CR Jr, Zeng L, Fan YF, Chen ZS (2021) Gold nanoparticles: synthesis, physiochemical properties and therapeutic applications in cancer. Drug Discov Today 26(5):1284–1292. https://doi.org/10.1016/j.drudis.2021.01.03010.1016/j.drudis.2021.01.030 ↗
87. Gupta AK, Gupta M (2005) Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 26(18):3995–4021. https://doi.org/10.1016/j.biomaterials.2004.10.01210.1016/j.biomaterials.2004.10.012 ↗
88. Mahmoudi M, Sant S, Wang B, Laurent S, Sen T (2011) Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy. Adv Drug Deliv Rev 63(1–2):24–46. https://doi.org/10.1016/j.addr.2010.05.00610.1016/j.addr.2010.05.006 ↗